Works matching IS 03682811 AND DT 2018 AND VI 48 AND IP 9


Results: 15
    1
    2
    3
    4
    5
    6

    A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 9, p. 855, doi. 10.1093/jjco/hyy097
    By:
    • Yamamoto, Yutaka;
    • Iwata, Hiroji;
    • Ueno, Takayuki;
    • Taira, Naruto;
    • Kashiwaba, Masahiro;
    • Takahashi, Masato;
    • Tada, Hiroshi;
    • Tsugawa, Koichiro;
    • Toyama, Tatsuya;
    • Niikura, Naoki
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    IN THIS ISSUE.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 9, p. 1, doi. 10.1093/jjco/hyy124
    Publication type:
    Article
    14
    15